A single-arm study of sublobar resection for ground-glass opacity dominant peripheral lung cancer
- PMID: 33487427
- DOI: 10.1016/j.jtcvs.2020.09.146
A single-arm study of sublobar resection for ground-glass opacity dominant peripheral lung cancer
Abstract
Background: The optimal mode of surgery for ground-glass opacity dominant peripheral lung cancer defined with thoracic thin-section computed tomography remains unknown.
Methods: We conducted a single-arm confirmatory trial to evaluate the efficacy and safety of sublobar resection for ground-glass opacity dominant peripheral lung cancer. Lung cancer with maximum tumor diameter 2.0 cm or less and with consolidation tumor ratio 0.25 or less based on thin-section computed tomography were registered. The primary end point was 5-year relapse-free survival. The planned sample size was 330 with the expected 5-year relapse-free survival of 98%, threshold of 95%, 1-sided α of 5%, and power of 90%. The trial is registered with University Hospital Medical Information Network Clinical Trials Registry, number University Hospital Medical Information Network 000002008.
Results: Between May 2009 and April 2011, 333 patients were enrolled from 51 institutions. Median age was 62 years (interquartile range, 56-68), and 109 were smokers. Median maximum tumor diameter was 1.20 cm (1.00-1.54). Median maximum tumor diameter of consolidation was 0 (0.00-0.20). The primary end point, 5-year relapse-free survival, was estimated on 314 patients who underwent sublobar resection. Operative modes were 258 wide wedge resections and 56 segmentectomies. Median pathological surgical margin was 15 mm (0-55). The 5-year relapse-free survival was 99.7% (90% confidence interval, 98.3-99.9), which met the primary end point. There was no local relapse. Grade 3 or higher postoperative complications based on Common Terminology Criteria for Adverse Effect v3.0 were observed in 17 patients (5.4%), without any grade 4 or 5.
Conclusions: Sublobar resection with enough surgical margin offered sufficient local control and relapse-free survival for lung cancer clinically resectable N0 staged by computed tomography with 3 or fewer peripheral lesions 2.0 cm or less amenable to sublobar resection and with a consolidation tumor ratio of 0.25 or less.
Keywords: GGO; lung cancer; prognosis; sublobar resection.
Copyright © 2020. Published by Elsevier Inc.
Comment in
-
Commentary: Is sublobar resection enough for ground-glass opacity-dominant lung adenocarcinoma?J Thorac Cardiovasc Surg. 2022 Jan;163(1):303-304. doi: 10.1016/j.jtcvs.2020.09.126. Epub 2020 Oct 8. J Thorac Cardiovasc Surg. 2022. PMID: 33158561 No abstract available.
-
Commentary: Ground-glass opacity-dominant lung cancer. Is every R0 wedge resection always a good wedge resection?J Thorac Cardiovasc Surg. 2022 Jan;163(1):305-306. doi: 10.1016/j.jtcvs.2020.10.023. Epub 2020 Oct 13. J Thorac Cardiovasc Surg. 2022. PMID: 33158564 No abstract available.
-
Commentary: Sublobar resection, closing in as the standard in surgical management for a subgroup of patients with lung cancer.J Thorac Cardiovasc Surg. 2022 Jan;163(1):302-303. doi: 10.1016/j.jtcvs.2020.10.035. Epub 2020 Oct 17. J Thorac Cardiovasc Surg. 2022. PMID: 33189335 No abstract available.
Similar articles
-
Long-term outcome of patients with peripheral ground-glass opacity-dominant lung cancer after sublobar resections.J Thorac Cardiovasc Surg. 2023 Oct;166(4):1222-1231.e1. doi: 10.1016/j.jtcvs.2023.01.019. Epub 2023 Jan 25. J Thorac Cardiovasc Surg. 2023. PMID: 37704343
-
Surgical outcome of wide wedge resection in poor-risk patients with clinical-N0 non-small cell lung cancer.Gen Thorac Cardiovasc Surg. 2017 Oct;65(10):581-586. doi: 10.1007/s11748-017-0803-z. Epub 2017 Jul 26. Gen Thorac Cardiovasc Surg. 2017. PMID: 28748318
-
A prospective 10-year follow-up study after sublobar resection for ground-glass opacity-dominant lung cancer.Sci Rep. 2024 Sep 11;14(1):21243. doi: 10.1038/s41598-024-72248-8. Sci Rep. 2024. PMID: 39261621 Free PMC article.
-
Non-small cell lung cancer: when to offer sublobar resection.Lung Cancer. 2014 Nov;86(2):115-20. doi: 10.1016/j.lungcan.2014.09.004. Epub 2014 Sep 16. Lung Cancer. 2014. PMID: 25249427 Review.
-
[JCOG lung cancer surgery trial series: review and interpretation].Zhonghua Zhong Liu Za Zhi. 2022 Jul 23;44(7):703-711. doi: 10.3760/cma.j.cn112152-20220511-00325. Zhonghua Zhong Liu Za Zhi. 2022. PMID: 35880335 Review. Chinese.
Cited by
-
[Research Progress in the Effect of Consolidation Tumor Ratio on the Diagnosis and Treatment of Early-stage Peripheral Lung Cancer].Zhongguo Fei Ai Za Zhi. 2022 Oct 20;25(10):764-770. doi: 10.3779/j.issn.1009-3419.2022.102.40. Zhongguo Fei Ai Za Zhi. 2022. PMID: 36285393 Free PMC article. Chinese.
-
Lack of incremental value of three-dimensional measurement in assessing invasiveness for lung cancer.Eur J Cardiothorac Surg. 2023 Dec 1;64(6):ezad373. doi: 10.1093/ejcts/ezad373. Eur J Cardiothorac Surg. 2023. PMID: 37975876 Free PMC article.
-
Therapeutic strategy for lung adenocarcinoma with pure ground-glass opacity: surgery, radiotherapy, or watchful waiting?J Thorac Dis. 2024 Jan 30;16(1):804-806. doi: 10.21037/jtd-23-1633. Epub 2024 Jan 15. J Thorac Dis. 2024. PMID: 38410555 Free PMC article. No abstract available.
-
Development and validation of qualitative and quantitative models to predict invasiveness of lung adenocarcinomas manifesting as pure ground-glass nodules based on low-dose computed tomography during lung cancer screening.Quant Imaging Med Surg. 2022 May;12(5):2917-2931. doi: 10.21037/qims-21-912. Quant Imaging Med Surg. 2022. PMID: 35502397 Free PMC article.
-
Augmented reality-assisted localization of solitary pulmonary nodules for precise sublobar lung resection: a preliminary study using an animal model.Transl Lung Cancer Res. 2021 Nov;10(11):4174-4184. doi: 10.21037/tlcr-21-554. Transl Lung Cancer Res. 2021. PMID: 35004248 Free PMC article.
MeSH terms
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical
Miscellaneous